CLINICAL_TRIALS
withdrawal
· 2016-11-08
Clinical Trial Update: The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives [Phase 4]
Summary
A Phase 4 trial evaluating vilazodone's effect on glutamate in the anterior cingulate cortex for patients with anxious major depressive disorder has been withdr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Anxiety | Phase 4 | Status: WITHDRAWN